We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 123 → 0 (-123)

100% less capital invested

Capital invested by funds: $487M → $0 (-$487M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

Holders
–
Holders Change
-123
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$35.4M
2
BIT
BlackRock Institutional Trust
California
-$31.5M
3
TAL
TIG Advisors LLC
New York
-$30.8M
4
State Street
State Street
Massachusetts
-$30.1M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
– -$538K -63,415 Closed
VKH
77
Virtu KCG Holdings
New York
– -$518K -60,982 Closed
Fidelity Investments
78
Fidelity Investments
Massachusetts
– -$509K -60,000 Closed
RFC
79
Russell Frank Company
Washington
– -$471K -55,488 Closed
SKK
80
Shepherd Kaplan Krochuk
Massachusetts
– -$450K -53,042 Closed
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
– -$448K -52,800 Closed
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
– -$440K -51,782 Closed
PGFC
83
Peapack-Gladstone Financial Corp
New Jersey
– -$425K -50,000 Closed
WB
84
WesBanco Bank
West Virginia
– -$425K -50,000 Closed
PA
85
Perceptive Advisors
New York
– -$400K -47,098 Closed
CCM
86
Cadence Capital Management
Massachusetts
– -$373K -43,990 Closed
Citigroup
87
Citigroup
New York
– -$323K -37,926 Closed
JG
88
Jefferies Group
New York
– -$313K -36,900 Closed
Principal Financial Group
89
Principal Financial Group
Iowa
– -$246K -29,035 Closed
Citadel Advisors
90
Citadel Advisors
Florida
– -$228K -26,880 Closed
UBS AM
91
UBS AM
Illinois
– -$222K -26,200 Closed
TCM
92
Touradji Capital Management
Florida
– -$212K -25,000 Closed
Prudential Financial
93
Prudential Financial
New Jersey
– -$204K -24,034 Closed
QI
94
Quotient Investors
New York
– -$170K -20,100 Closed
CCA
95
Catalyst Capital Advisors
New York
– -$170K -20,000 Closed
PP
96
Paloma Partners
Connecticut
– -$160K -18,854 Closed
DTL
97
Dynamic Technology Lab
Singapore
– -$150K -17,698 Closed
TRCT
98
Tower Research Capital (TRC)
New York
– -$136K -15,942 Closed
PAIM
99
Punch & Associates Investment Management
Minnesota
– -$122K -14,330 Closed
DIA
100
Denver Investment Advisors
Colorado
– -$121K -14,256 Closed
1 2 3
4
5

ASTX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q4 2013, worth a combined $0 — down 100% from $487M a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of ASTX and 0 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $35.4M sold.

  • 0 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q4 2013, down from 123 in Q3 2013.
  • Funds reported $0 of ASTEX PHARMACEUTICALS, INC COM stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q4 2013 and 123 closed out, a net change of -123 holders.
  • The largest ASTEX PHARMACEUTICALS, INC COM seller in Q4 2013 was BlackRock Fund Advisors, an estimated $35.4M sold.

Based on aggregated 13F filings for Q4 2013.